[TimAlerts] HSGX up ah on news (44.7%). Positive Phase 1 and 2 clinical data novel treatment for chondrosis (cartilage loss). 12M float though. Going on the watch list.

[TimAlerts] $MEET positive earnings

[TimAlerts] Nice close on VBIO

[TimAlerts] For what it is worth, FDA approval usually takes greater than a decade to move from lab and randomized clinical trial to human use. Furthermore, only about 0.1% of all new drugs pass the FDA process. The news on VCEL is very huge for the company.

[TimAlerts] FYI any AKAO longs, $14.96 most recent a/h trading.

[TimAlerts] ABUS after market gainer. Pharmaceutical company with positive clinical data in treatment of hepatitis.

[TimAlerts] Long $LIVE

[TimAlerts] $LIVE could hit NHD